Summary & Overview
HCPCS J7342: Ciprofloxacin Otic Suspension Instillation, 6 mg
HCPCS Level II code J7342 denotes the instillation of ciprofloxacin otic suspension, 6 mg, used for topical antibiotic treatment in the ear. As a drug administration code for an otic suspension, J7342 is relevant to outpatient and ambulatory care billing where ear infections or post-procedural otic indications require topical antibiotic therapy. Nationally, accurate reporting of this code affects drug utilization tracking, pharmacy-medical billing alignment, and payment for administered medications.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for use of ciprofloxacin otic suspension, standard sites of service for instillation, common billing modifiers (listed separately), and where available, benchmarking and policy considerations that affect coverage and reimbursement. The publication outlines coding guidance, common payer approaches to drug administration claims, and operational considerations for documentation and claim submission.
This summary provides clinicians, billing staff, and policy analysts with the core facts needed to identify when J7342 applies, understand payer landscape coverage at a national level, and locate related resources for coding and billing decisions. Data not available in the input will be noted in relevant sections.
Billing Code Overview
HCPCS Level II code J7342 represents the instillation of ciprofloxacin otic suspension, 6 mg. This code describes a topical antibiotic ear drop preparation administered for otic (ear) use.
-
Service type: Instillation of a topical otic antibiotic
-
Typical site of service: Outpatient clinic, physician office, urgent care, or other ambulatory settings where topical otic medications are administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric patient presenting to an outpatient otolaryngology clinic, urgent care, emergency department, or primary care office with acute otitis externa or postoperative external auditory canal infection following ear surgery or tympanostomy tube placement. The clinician performs an otoscopic exam identifying purulent or mucopurulent drainage, erythema, edema of the canal, or confirmed superficial bacterial infection where topical fluoroquinolone therapy is indicated. The provider selects J7342 for documentation and billing when instilling ciprofloxacin otic suspension, 6 mg, as a single-dose instillation or as part of supervised administration during the visit. Typical workflow: patient assessment and otoscopic examination → diagnosis coding and shared decision for topical therapy → preparation of medication and instillation by the clinician or supervised administration by nursing staff → patient education on home drops if a prescription or sample is provided → documentation of drug name, dose, route (otic), lot number if applicable, and any observed immediate reaction.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Rarely used; default when no other modifier applies to the service |